Network Engineer II (Remote)
KUBRASalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries
Requirements
Candidates should possess at least 8 years of experience in network architecture, implementation, and administration within an enterprise environment, along with domain expertise in WAN, LAN, Wireless, DDI (DNS, DHCP, IPAM), VPN, OOB, Network Security – Firewalls, IPS, Secure Access, Network Access Control, Network Monitoring and Alerting, and Capacity Planning. Strong technical knowledge of Cisco Catalyst/Nexus, Cisco SD-WAN, Meraki and Cisco WLC Wireless, Cisco ISE, Palo Alto Firewalls, Juniper SRX and Infoblox DDI solutions is required.
Responsibilities
The Senior Network Engineer will design, implement, and manage enterprise-level network infrastructure, including routing, switching, wireless, firewalls, VPN, and network security solutions. They will continuously monitor network performance metrics, proactively identifying and addressing performance bottlenecks and security vulnerabilities, and partner with security teams to enforce network security best practices. The role involves leading network lifecycle management, including architecture upgrades and hardware/software refreshes, supporting global network availability and security compliance, and driving network automation initiatives utilizing tools such as Python, Ansible, and Terraform. Additionally, the engineer will provide leadership in network incident resolution, RCA (Root Cause Analysis), and post-mortem documentation, and participate in a global on-call rotation as Tier 3 escalation point.
Skills
Network Design
Routing
Switching
Wireless
Firewalls
VPN
Network Security
Hardware and Software Evaluation
Network Infrastructure Management
Performance Monitoring
Security Best Practices
Firewall Configuration
Access Controls
IPS/IDS
Vendor Collaboration
Moderna
Develops mRNA-based medicines for health
About Moderna
Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.
Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees